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Abstract: Systemic anaplastic large cell lymphomas (ALCLs) are
classiﬁed into ALK-positive and ALK-negative types. We recently
reported that ALK-negative ALCLs are genetically heterogenous.
The largest subset, representing 30% of cases, had rearrangements
of the DUSP22 locus. These cases had favorable outcomes similar
to ALK-positive ALCL, and superior to other ALK-negative
ALCLs. Here, we examined the morphologic features of these
cases in more detail. First, we conducted blinded review of hem-
atoxylin and eosin slides of 108 ALCLs from our previous study,
scoring cases for the presence of 3 histologic patterns and 5 cell
types. Cases then were unblinded and re-reviewed to understand
these features further. DUSP22-rearranged ALCLs were more
likely than other ALK-negative ALCLs to have so-called
doughnut cells (23% vs. 5%; P=0.039), less likely to have
pleomorphic cells (23% vs. 49%; P=0.042), and nearly always
(95%) had areas with sheet-like growth (common pattern). To
examine the reproducibility of these ﬁndings, we conducted
blinded review of hematoxylin and eosin slides of 46 additional
ALK-negative ALCLs using a 0 to 3 scoring system to predict
likelihood of DUSP22 rearrangement, the results of which cor-
related strongly with subsequent ﬁndings by ﬂuorescence in situ
hybridization (P<0.0001). Although all ALCLs share certain
morphologic features, ALCLs with DUSP22 rearrangements
show signiﬁcant diﬀerences from other ALK-negative ALCLs,
typically showing sheets of hallmark cells with doughnut cells and
few large pleomorphic cells. These morphologic ﬁndings and our
previous outcome data suggest that ALK-positive ALCLs and
DUSP22-rearranged ALCLs represent prototypical ALCLs,
whereas ALCLs lacking rearrangements of both DUSP22 and
ALK require further study.
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Anaplastic large cell lymphomas (ALCLs) represent agroup of CD30-positive T-cell non-Hodgkin lym-
phomas that vary in their genetics, clinical presentation,
and biological behavior. The World Health Organization
recognizes 3 distinct types of ALCL: systemic ALK-pos-
itive ALCL, systemic ALK-negative ALCL, and primary
cutaneous ALCL.1 Systemic ALK-positive ALCLs con-
sistently have rearrangements of the ALK gene and have
favorable outcomes in most cases after standard combi-
nation chemotherapy.2 In contrast, systemic ALK-neg-
ative ALCLs lack ALK rearrangements and as a whole
have inferior outcomes than ALK-positive ALCLs.3 We
recently showed, however, that ALK-negative ALCL is a
genetically and a clinically heterogenous entity.4 Thirty
percent of cases bear rearrangements of the DUSP22-
IRF4 locus on 6p25.3 (DUSP22 rearrangements),5,6 and
these cases have favorable outcomes similar to those of
ALK-positive ALCL. A smaller fraction of patients
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(B8%) have rearrangements of TP637 and have very
poor outcomes, whereas the remaining cases lack re-
arrangements of ALK, DUSP22, and TP63 (“triple-neg-
ative” ALCLs) and have intermediate outcomes.
The morphologic features of ALCL have been studied
extensively, particularly in ALK-positive cases. Several his-
tologic patterns, including the common, lymphohistiocytic,
Hodgkin-like, and small-cell patterns, have been described;
the ability to identify ALK rearrangements or expression of
the resultant ALK fusion proteins in these cases led to rec-
ognition that these patterns could be uniﬁed into a single
clinicopathologic entity.8 Among ALK-negative ALCLs, the
lack of a unifying ﬁnding such as ALK expression has made
the inclusion of variant histologic patterns more challenging,
but a spectrum of morphologic features may be seen in this
disease, with the exception of a small-cell pattern.9 All
ALCLs share the feature of containing a cell type with
characteristic cytologic features, including a kidney-shaped or
horseshoe-shaped nucleus, and designated the hallmark cell.8
However, the number of typical hallmark cells varies among
cases, as does the number of other cell types, including so-
called “doughnut” cells with central nuclear pseudoinclu-
sions, immunoblastic cells, and large, pleomorphic cells that
sometimes have nuclei with a “wreath-like” appearance.
Despite the above observations, diagnostic criteria to
distinguish ALK-negative ALCL from other CD30-positive
T-cell non-Hodgkin lymphomas, particularly peripheral
T-cell lymphoma, not otherwise speciﬁed (PTCL, NOS),
remain imprecise and somewhat controversial.3,9–11 There-
fore, in our recent study on the genetics of ALK-negative
ALCL,4 we used a 2-tiered, blinded review by a panel
of expert hematopathologists (E.S.J., J.S., and S.H.S.) to
select cases for inclusion. The ﬁrst tier consisted of assessing
whether classic features of ALCL were present on the basis
of a hematoxylin and eosin (H&E)–stained slide and the
pattern of CD30 immunostaining. Interestingly, the highest
consensus on the presence of classic features of ALCL was
observed for cases with DUSP22 rearrangements. In addi-
tion, the highest consensus on a final diagnosis of ALK-
negative ALCL was observed for cases with DUSP22
rearrangements after second-tier review, which included
additional immunophenotypic data. However, the specific
morphologic findings responsible for these associations
could not be ascertained because they were not scored
prospectively and because the first-tier analysis also in-
cluded the CD30 staining pattern. Therefore, we undertook
the present study to characterize the morphologic features
of ALK-negative ALCLs with DUSP22 rearrangements.
METHODS
Two study groups were analyzed. Study group 1
consisted of 108 systemic ALCLs (77 ALK-negative, 31
ALK-positive) assessed in our previous study.4 One ALK-
positive ALCL from that study was not available for re-
view. Four ALK-negative ALCLs that had been assessed
previously but not reported because of lack of clinical
outcome data were included in the present study. Morpho-
logic assessments were performed by 3 hematopathologists
(R.L.K., L.N.D, and E.D.M.) not involved in our pre-
viously published series of ALCLs. H&E slides were re-
viewed without any additional immunostains. Aside from
knowing that all patients carried a diagnosis of ALCL,
reviewers were blinded to all additional clinicopathologic
data, including ALK status and genetic results. The pres-
ence of 3 histologic patterns and 5 cell types were scored
independently by each reviewer. The histologic patterns
included the common pattern, the lymphohistiocytic pat-
tern, and the Hodgkin-like pattern.8 Although the common
pattern as used in the World Health Organization classi-
ﬁcation reﬂects both the architectural pattern and the cy-
tologic features of the tumor cells,12 here we emphasized the
characteristic of sheet-like growth as cytologic features
were considered separately. Cases with a small-cell pattern
were excluded because an ALK-negative form is not rec-
ognized.9 Cell types assessed were hallmark cells, dough-
nut cells, immunoblasts, large pleomorphic cells, and
wreath-like cells. Each pattern or cell type was scored as
“predominant,” “present but not predominant,” or
“absent.” The presence of sinusoidal involvement also was
noted. Final scores were determined by majority.
After all cases in study group 1 were scored, associa-
tions between morphologic ﬁndings and genetics were as-
sessed. H&E sections were re-reviewed jointly by R.L.K.,
L.N.D, E.D.M., and A.L.F. in the context of the genetic
ﬁndings to identify a constellation of features most con-
sistently associated with DUSP22 rearrangements. Reviewers
then used the results from both the blinded analysis and the
unblinded group review of study group 1 as a knowledge
base from which to assess H&E-stained sections for study
group 2, consisting of an independent set of 46 systemic
ALK-negative ALCLs of unknown genetic status. Cases
were scored on the basis of a histologic score that ranged
from 0 to 3, where 0 was predicted to be least likely to bear a
DUSP22 rearrangement and 3 most likely. Discrete criteria
for assigning a particular score were not utilized; reviewers
used the constellation of features identiﬁed from study group
1 to assess the likelihood of DUSP22 rearrangement in a
given case. Genetic status was determined as previously de-
scribed.4 All cases were evaluated for DUSP22 rearrange-
ments by ﬂuorescence in situ hybridization (FISH). Cases
were also stained for p63, and cases with >30% positive
tumor cell nuclei were evaluated by both breakapart FISH
for TP63 and dual-fusion FISH for TBL1XR1/TP63. Im-
munostains for p63 and TIA1 were performed as previously
described (2/46 cases did not have sections available for TIA1
staining).4 Groups were compared using the 2-tailed Fisher
exact test, Wilcoxon test, or Cochran-Armitage trend test, as
appropriate; P values of <0.05 were considered statistically
signiﬁcant. Research was conducted under a protocol ap-
proved by the Mayo Clinic Institutional Review Board.
RESULTS
Study Group 1
Demographic data for the 108 cases (31 ALK-pos-
itive and 77 ALK-negative) in study group 1 are shown
in Table 1. Among the ALK-negative ALCLs, there were
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22 with DUSP22 rearrangements (28%), 6 with TP63
rearrangements (8%), and 49 triple-negative ALCLs
(64%). Because TP63 rearrangements were infrequent
and were not the subject of this study, these cases and
triple-negative cases were combined into a single category
of ALK-negative ALCLs lacking DUSP22 rearrange-
ments in subsequent analyses. The common pattern
(sheet-like growth) was the most frequently observed in
all genetic subtypes (Table 2, Supplemental Table 1,
Supplemental Digital Content 1, http://links.lww.com/
PAS/A307). Although not signiﬁcant, areas with the
common pattern were present in DUSP22-rearranged
ALCLs more frequently than in other ALK-negative
ALCLs (95% vs. 80%; P=0.16) and at a frequency
similar to ALK-positive ALCLs. A representative case of
common-pattern ALK-negative ALCL with DUSP22
rearrangement is shown in Figures 1A–D. A single case
with DUSP22 rearrangement and a lymphohistiocytic
pattern was seen (Fig. 1E). DUSP22 rearrangements were
not observed in cases with Hodgkin-like features.
The hallmark cell was the predominant cell type in
the majority of cases in all subgroups. DUSP22-rearranged
ALCLs were more likely than other ALK-negative ALCLs
to have doughnut cells (23% vs. 5%; P=0.039; Fig. 1A,
inset) and less likely to have large pleomorphic cells (23%
vs. 49%; P=0.042; Figs. 1F, G). Large pleomorphic cells
were not the predominant cell type in any case with
DUSP22 rearrangement. The presence of a sinusoidal
growth pattern could not be assessed in a suﬃcient number
of cases to be analyzed further, mostly due to either small
size or an extranodal site of the biopsy.
Re-review of Study Group 1
Upon unblinded joint re-review of the cases in study
group 1, the observations noted above were expanded.
Cases with DUSP22 rearrangements typically showed
sheets of hallmark cells, sometimes including doughnut
cells. Hallmark cells can show varying nuclear features,
including horseshoe-shaped nuclei with very pro-
minent invaginations and kidney-shaped nuclei with a
lesser degree of indentation, which result in a variety of











Age, mean (range) (y)
Study group 1 32 (6-77) 60 (24-95) 59 (37-77) 52 (31-75) 62 (24-95)
Study group 2 — 62 (32-89) 63 (33-81) 70 (66-75) 62 (32-89)
Sex: M:F
Study group 1 20:11 52:25 15:7 3:3 34:15
Study group 2 — 29:17 12:4 1:1 16:12
Distribution of rearrangements: n (% of ALK-negative cases)
Study group 1 31 (—)* 77 (100) 22 (29) 6 (8) 49 (63)
Study group 2 — 46 (100) 16 (35) 2 (4) 28 (61)
*This set of ALK-positive ALCLs was included in study group 1 as a reference, and the number of cases does not reﬂect the relative frequency of ALK positivity across all ALCLs.





DUSP22 Rearrangement, n (%) P
ALK-negative, No
DUSP22 Rearrangement, n (%)
Histologic pattern(s) present*
Common 28 (90) 0.63 21 (95) 0.16 44 (80)
Lymphohistiocytic 6 (19) 0.45 2 (9) 0.72 8 (14)
Hodgkin-like 0 (0) 1.00 0 (0) 0.32 4 (7)
Cell type(s) present*
Hallmark 31 (100) 1.00 22 (100) 1.00 53 (96)
Doughnut 5 (16) 0.72 5 (23) 0.04 3 (5)
Immunoblast 6 (19) 0.72 3 (13) 0.75 11 (20)
Large pleomorphic 12 (38) 0.25 5 (23) 0.04 27 (49)
Wreath-like 1 (3) 1.00 1 (4) 0.16 10 (18)
No. cases evaluated 31 22 55
*Percentages may total >100% because reviewers could select >1 histologic pattern or cytology for each case, if appropriate.
Bold values are statistically signiﬁcant.
P values: Fisher exact test.
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FIGURE 1. Morphologic patterns in ALK-negative ALCL. A, Typical case of ALK-negative ALCL with DUSP22 rearrangement (H&E).
This case represents the so-called “common” pattern, with sheets of tumor cells including numerous hallmark cells (inset, left; H&E)
and occasional “doughnut” cells (inset, right). The tumor cells are strongly and uniformly positive for CD30 (B) and negative for ALK
(C). D, FISH using a breakapart probe to the DUSP22 locus shows a rearrangement, with 1 normal fusion signal (f ) and an abnormal
split signal (s). E, Sole example from study group 1 of ALK-negative ALCL with DUSP22 rearrangement and a lymphohistiocytic
pattern (H&E). The tumor cells are scattered in a background rich in small lymphocytes and histiocytes. Hallmark cells are present
(inset; H&E). F, ALK-negative ALCL with large pleomorphic cells (H&E), including cells with wreath-like nuclei (inset; H&E). This case
was a “triple-negative” ALCL. G, Another triple-negative ALCL composed predominantly of large pleomorphic cells (H&E). Cells with
wreath-like nuclei were infrequent in this case, but other multinucleate forms were easily identified (inset; H&E). Large pleomorphic
cells could be seen occasionally in DUSP22-rearranged ALCLs, but were not the predominant cell type.
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appearances depending upon the plane of sectioning
through a given cell (Fig. 2A). Therefore, the 3-dimen-
sional conﬁguration of the cells must be reconstructed
mentally on the basis of evaluation of the full spectrum of
nuclear features observed. Consistent with the increased
presence of doughnut cells in DUSP22-rearranged
ALCLs, hallmark cells in these cases tended to show more
nuclear invagination than in other ALK-negative ALCLs,
which tended to be more kidney-shaped (Figs. 2B, C).
Some accentuation of nuclear indentation could be seen
even in DUSP22-rearranged ALCLs without doughnut
cells. It also was noted upon re-review that the tumor cells
in some cases with DUSP22 rearrangements appeared
slightly smaller than the tumor cells of other ALCLs of
the common pattern, and the nuclear chromatin was
slightly more condensed (Fig. 2D). The cell size often was
quite uniform, and admixed inﬂammatory cells were ab-
sent, giving these cases a monotonous appearance. Al-
though the cells were small to medium in size, the features
were not those of the small-cell variant of ALK-positive
ALCL, in which only rare hallmark cells can be identiﬁed
and the majority of cells have irregular nuclear contours
and moderate clear to weakly basophilic cytoplasm.13 In
contrast, these cases of DUSP22-rearranged ALCLs had a
relatively monomorphic population of typical hallmark
cells with smaller cell size. The combination of this
smaller cell size with the appearance of doughnut cells
(mini-doughnuts) was very suggestive of the presence of a
DUSP22 rearrangement.
The presence of large pleomorphic cells was con-
sidered atypical of cases with DUSP22 rearrangements.
This included not only the wreath-like nuclei that were
FIGURE 2. Additional morphologic features in ALK-negative ALCL. A, Hallmark cells show a spectrum of features; nuclei with very
prominent invaginations are horseshoe-shaped (left), whereas a lesser degree of indentation results in a kidney-shaped nucleus
(right). These give rise to different appearances depending on the plane of section. B, ALCLs with DUSP22 rearrangements were
noted to have prominent nuclear invagination, sometimes giving rise to numerous doughnut cells, as in this case (H&E).
Numerals denote cells with cytologic features as shown in (A). C, This case of triple-negative showed a common pattern with
predominantly hallmark cells, which had kidney-shaped rather than horseshoe-shaped nuclei (H&E). D, Some DUSP22-rearranged
ALCLs showed hallmark cells with relatively small, somewhat hyperchromatic nuclei in sheets without admixed acute in-
flammatory cells (H&E). A finding very suggestive of the presence of a DUSP22 rearrangement was the combination of this smaller
cell size with the appearance of doughnut cells (“mini-doughnuts”; inset; H&E). E, A finding uncommon in DUSP22-rearranged
ALCLs was the admixture of granulocytes or eosinophils, as in this triple-negative ALCL (H&E). Also note the larger cell size and
more open nuclear chromatin compared with (D).
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scored prospectively but a wide range of cytologic fea-
tures corresponding to bizarre nuclear shapes, multi-
nucleation, and Reed-Sternberg–like features. In general,
fewer background inflammatory cells were seen in
DUSP22-rearranged cases, and specifically the presence
of eosinophils was uncommon (Fig. 2E).
Study Group 2
Of the 46 ALK-negative ALCLs in study group 2,
there were 16 with DUSP22 rearrangements (35%), 2
with TP63 rearrangements (4%), and 28 triple-negative
ALCLs (61%). This distribution was similar to the rela-
tive frequencies of these genetic subtypes in our previous
report,4 as reﬂected by study group 1 (Table 1). Using the
constellation of histologic features identiﬁed from blinded
and unblinded review of study group 1, reviewers pro-
vided histologic scores that correlated signiﬁcantly with
the presence of DUSP22 rearrangements. Speciﬁcally, the
mean frequencies (±SD) of DUSP22 rearrangements in
cases given scores of 0, 1, 2, and 3 were 3.5%±7.0%,
24.5%±10.7%, 67.3%±15.7%, and 84.3%±20.5%,
respectively (P<0.0001; Fig. 3A). Therefore, despite the
subjective nature of this scoring system, reviewers could
identify and validate the constellation of histologic fea-
tures associated with DUSP22 rearrangements in an in-
dependent group of ALK-negative ALCLs.
We previously showed that, unlike many ALCLs,
those withDUSP22 rearrangements typically lack cytotoxic
marker expression.4,5 The strongest association was ob-
served for TIA1 expression, assessed by immunohisto-
chemistry.4 Therefore, we sought to determine whether
TIA1 expression could add to the ability of the histologic
score to predict the presence of a DUSP22 rearrangement.
The frequencies of DUSP22 rearrangements in ALK-neg-
ative ALCLs that were positive and negative for TIA1 were
6.7% and 48.3%, respectively (P=0.027; Fig. 3B), further
validating our previous ﬁndings. A histologic score of 2 or 3
was associated with a 69.5%±16.0% frequency of
DUSP22 rearrangement, compared with 18.8%±6.3%
for a histologic score of 0 or 1 (P=0.029; Fig. 3C). No
signiﬁcant increase in the predictive ability of a histologic
score of 2 or 3 was observed when negativity for TIA1 was
included as an additional criterion (76.0%±18.6%;
P=0.89).
DISCUSSION
This study is the ﬁrst to dissect the morphologic
features of systemic ALK-negative ALCLs with DUSP22
rearrangements. Next to ALK rearrangements, DUSP22
rearrangements are the second most common chromo-
somal rearrangements in ALCL. To date, DUSP22 re-
arrangements have been mutually exclusive with ALK
rearrangements, and both genetic subsets show similarly
favorable outcomes compared with other systemic
ALCLs and PTCLs; speciﬁcally, 5-year overall survival
rates were 90% for DUSP22-rearranged ALCLs and 85%
for ALK-positive ALCLs, compared with 17% and 42%
for TP63-rearranged ALCLs and triple-negative ALCLs,
respectively.4 Here, we have demonstrated that DUSP22-
rearranged ALCLs have a unique and reproducible con-
stellation of morphologic features recognizable on H&E
stains, further supporting the concept that these cases
represent a clinicopathologically distinct subset of
ALCLs.
The histologic features identiﬁed as associated with
DUSP22 rearrangements in this study recapitulate the
classic features of ALCL described in earlier morphologic
descriptions of this entity.8,14–16 Particularly, these cases
typically showed sheet-like growth of hallmark cells with
FIGURE 3. Correlates of a histologic score in study group 2 (n =46). A, Histologic score correlated closely with the frequency of
DUSP22 rearrangement in ALK-negative ALCLs. B, TIA1 expression also was inversely associated with the presence of DUSP22
rearrangement. C, A histologic score of 2 or 3 was associated with the presence of DUSP22 rearrangements, but adding TIA1
negativity to the histologic score did not increase the rearrangement frequency significantly.
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a tendency to have prominent nuclear indentations,
yielding a nuclear contour that is more horseshoe-shaped
than kidney-shaped. This prominent degree of in-
dentation accounts for the appearance of doughnut cells,
which are sectioned perpendicular to the axis of in-
dentation.17 Because most ALCL cells are relatively large
compared with the standard thickness of H&E sections,
the frequency of doughnut cells is proportional to the
extent of nuclear indentation. Doughnut cells were seen
with similar frequency in DUSP22-rearranged ALCLs and
ALK-positive ALCLs, but were uncommon in the other
genetic subgroups. Notably absent in ALCLs with DUSP22
rearrangements were the large pleomorphic cells in their
various manifestations (wreath-like, Reed-Sternberg–like,
etc.) that have been reported in both ALK-positive and
ALK-negative ALCLs. Furthermore, DUSP22-rearranged
cases with a lymphohistiocytic pattern were infrequent and
no cases with a Hodgkin-like pattern were seen. Although
cases with a Hodgkin-like pattern were included in the
original cohort, more recent studies suggest that such cases
be excluded from ALK-negative ALCL.10,11 Further studies,
including gene expression profiling and mutational analysis,
will be necessary to resolve the best way to classify these
atypical cases. Taken together, our findings suggest that
ALK-negative ALCLs with DUSP22 rearrangements rep-
resent prototypical ALCLs with a morphologic spectrum
narrower than that of ALK-positive ALCLs.
The presence of ALK rearrangements, determined
by immunohistochemistry or genetic tests, has allowed
inclusion of cases with variant histologic patterns in the
category of ALK-positive ALCL.8,12 The question arises
whether detection of DUSP22 rearrangements could play
a similar role in the diagnosis of ALK-negative ALCL. As
discussed above, the deﬁnition of ALK-negative ALCL is
evolving, and a certain degree of subjectivity remains in the
distinction from other mature T-cell lymphomas expressing
CD30.9 Although we have observed DUSP22 rearrange-
ments in cases with a submitting diagnosis of CD30-pos-
itive PTCL, NOS,5 all such cases were reclassiﬁed as
ALK-negative ALCL upon independent, blinded review in
our subsequent study.4 Therefore, identifying DUSP22 re-
arrangements by FISH might—in the proper clin-
icopathologic setting—be a useful tool in the diagnosis of
ALK-negative ALCL, defining a group of cases with
characteristic morphology, immunophenotype, and clinical
behavior.4 Of note, DUSP22 rearrangements can also be
seen in 28% of primary cutaneous ALCLs and even rarely
in lymphomatoid papulosis.18,19 Primary cutaneous ALCLs
also occasionally may be ALK-positive, albeit less com-
monly.20 Therefore, interpretation of any ALCL with skin
involvement requires correlation with staging and other
clinical data.
Although this study focused primarily on DUSP22-
rearranged ALCLs, a few comments on the remaining
subsets of ALK-negative ALCLs are warranted. First,
TP63-rearranged ALCLs are rare, and experience is lim-
ited. As in the case of DUSP22 rearrangements, cases
with TP63 rearrangements originally diagnosed as PTCL,
NOS were reclassiﬁed as ALK-negative ALCLs during
central review in our previous study.4 However, this re-
classiﬁcation was made with a slightly lower degree of
consensus than for DUSP22-rearranged cases, and in our
opinion too few TP63-rearranged ALCLs have been re-
ported to draw conclusions about their general character-
istics. Nevertheless, like DUSP22-rearranged cases, TP63-
rearranged ALCLs did not tend to have large pleomorphic
cells, which were observed almost exclusively in triple-
negative ALCLs and ALK-positive ALCLs. Not all triple-
negative ALCLs had these features, suggesting that further
heterogeneity may exist within this subgroup independent
of the rearrangements studied here.
REFERENCES
1. Swerdlow S, Campo E, Harris N, et al. WHO Classification of
Tumours of Haematopoietic and Lymphoid Tissues. Lyon: Interna-
tional Agency for Research on Cancer; 2008.
2. Gascoyne RD, Aoun P, Wu D, et al. Prognostic significance
of anaplastic lymphoma kinase (ALK) protein expression in
adults with anaplastic large cell lymphoma. Blood. 1999;93:
3913–3921.
3. Savage KJ, Harris NL, Vose JM, et al. ALK anaplastic large-cell
lymphoma is clinically and immunophenotypically different from
both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise
specified: report from the International Peripheral T-Cell Lympho-
ma Project. Blood. 2008;111:5496–5504.
4. Parrilla Castellar ER, Jaffe ES, Said JW, et al. ALK-negative
anaplastic large cell lymphoma is a genetically heterogeneous disease
with widely disparate clinical outcomes. Blood. 2014;124:1473–1480.
5. Feldman AL, Law M, Remstein ED, et al. Recurrent translocations
involving the IRF4 oncogene locus in peripheral T-cell lymphomas.
Leukemia. 2009;23:574–580.
6. Feldman AL, Dogan A, Smith DI, et al. Discovery of recurrent
t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large
cell lymphomas by massively-parallel genomic sequencing. Blood.
2011;117:915–919.
7. Vasmatzis G, Johnson SH, Knudson RA, et al. Genome-wide
analysis reveals recurrent structural abnormalities of TP63 and other
p53-related genes in peripheral T-cell lymphomas. Blood. 2012;120:
2280–2289.
8. Benharroch D, Meguerian-Bedoyan Z, Lamant L, et al. ALK-
positive lymphoma: a single disease with a broad spectrum of
morphology. Blood. 1998;91:2076–2084.
9. Mason DY, Harris NL, Delsol G, et al. Anaplastic large cell
lymphoma, ALK-negative. In: Swerdlow S, Campo E, Harris N,
et al, eds. WHO Classification of Tumours of Haematopoietic and
Lymphoid Tissues. Lyon: International Agency for Research on
Cancer; 2008:317–319.
10. Klapper W. What is a true ALCL? Blood. 2014;124:1385–1386.
11. Attygalle AD, Cabecadas J, Gaulard P, et al. Peripheral T-cell and
NK-cell lymphomas and their mimics; taking a step forward—
report on the lymphoma workshop of the XVIth meeting of the
European Association for Haematopathology and the Society for
Hematopathology. Histopathology. 2014;64:171–199.
12. Delsol G, Falini B, Muller-Hermelink HK, et al. Anaplastic large
cell lymphoma, ALK-positive. In: Swerdlow S, Campo E, Harris N,
et al, eds. WHO Classification of Tumours of Haematopoietic and
Lymphoid Tissues. Lyon: International Agency for Research on
Cancer; 2008:312–316.
13. Kinney M, Collins R, Greer J, et al. A small-cell-predominant
variant of primary Ki-1 (CD30)+ T-cell lymphoma. Am J Surg
Pathol. 1993;17:859–868.
14. Stein H, Mason D, Gerdes J, et al. The expression of the Hodgkin’s
disease associated antigen Ki-1 in reactive and neoplastic lymphoid
tissue: evidence that Reed-Sternberg cells and histiocytic malignan-
cies are derived from activated lymphoid cells. Blood. 1985;66:
848–858.
King et al Am J Surg Pathol  Volume 40, Number 1, January 2016
42 | www.ajsp.com Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
15. Agnarsson B, Kadin M. Ki-1 positive large cell lymphoma: a
morphologic and immunologic study of 19 cases. Am J Surg Pathol.
1988;12:264–274.
16. Bitter MA, Franklin WA, Larson RA, et al. Morphology in Ki-
1(CD30)-positive non-Hodgkin’s lymphoma is correlated with
clinical features and the presence of a unique chromosomal
abnormality, t(2;5)(p23;q35). Am J Surg Pathol. 1990;14:305–316.
17. Jaffe ES. Post-thymic T-cell lymphomas. In: Jaffe ES, ed. Surgical
Pathology of the Lymph Nodes and Related Organs. Philadelphia,
PA: W.B. Saunders; 1995:344–389.
18. Wada DA, Law ME, Hsi ED, et al. Specificity of IRF4 translocations
for primary cutaneous anaplastic large cell lymphoma: a multicenter
study of 204 skin biopsies. Mod Pathol. 2011;24:596–605.
19. Karai LJ, Kadin ME, Hsi ED, et al. Chromosomal rearrangements
of 6p25.3 define a new subtype of lymphomatoid papulosis. Am J
Surg Pathol. 2013;37:1173–1181.
20. Oschlies I, Lisfeld J, Lamant L, et al. ALK-positive anaplastic large
cell lymphoma limited to the skin: clinical, histopathological and
molecular analysis of 6 pediatric cases. A report from the
ALCL99 study. Haematologica. 2013;98:50–56.
Am J Surg Pathol  Volume 40, Number 1, January 2016 Morphology of ALK-negative ALCL
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved. www.ajsp.com | 43
Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
